Novartis AG ADR
Drug Manufacturers - General
Healthcare
NVS
1.98 B shares
NYSE US
traded
23 Sep 2025
listed
no
open
122.99
52 week high
129.73
high
123.40
52 week low
0.00
low
122.54
growth
5.93 %
previous Close
123.36
P/E ratio
54
market cap
237 B
div yield
0
usd
Mar 2025
qoq
revenue
13.62 B
0.46 %
net incoming
3.61 B
27.96 %
eps
2.28 %
15.15 %
eps surprise
5.07 %
net profit margin
26.48 %
5.00 %
operating incoming
4.66 B
32.10 %
net change in cash
-4.39 B
-104.33 %
cash on hand
7.07 B
-38.34 %
cost of revenue
3.23 B
-2.92 %
top top